China · Delayed Price · Currency is CNY Kangmei Pharmaceutical Statistics
Total Valuation
SHA:600518 has a market cap or net worth of CNY 18.67 billion. The enterprise value is 17.53 billion.
| Market Cap | 18.67B |
| Enterprise Value | 17.53B |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:600518 has 13.83 billion shares outstanding. The number of shares has decreased by -17.16% in one year.
| Current Share Class | 13.83B |
| Shares Outstanding | 13.83B |
| Shares Change (YoY) | -17.16% |
| Shares Change (QoQ) | -54.97% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 8.34% |
| Float | 10.22B |
Valuation Ratios
The trailing PE ratio is 633.68.
| PE Ratio | 633.68 |
| Forward PE | n/a |
| PS Ratio | 3.76 |
| PB Ratio | 2.54 |
| P/TBV Ratio | 2.71 |
| P/FCF Ratio | 1,581.63 |
| P/OCF Ratio | 81.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 298.21, with an EV/FCF ratio of 1,485.07.
| EV / Earnings | 594.99 |
| EV / Sales | 3.53 |
| EV / EBITDA | 298.21 |
| EV / EBIT | n/a |
| EV / FCF | 1,485.07 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.31 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 2.87 |
| Debt / FCF | 14.31 |
| Interest Coverage | -13.43 |
Financial Efficiency
Return on equity (ROE) is 0.43% and return on invested capital (ROIC) is -2.20%.
| Return on Equity (ROE) | 0.43% |
| Return on Assets (ROA) | -1.13% |
| Return on Invested Capital (ROIC) | -2.20% |
| Return on Capital Employed (ROCE) | -3.04% |
| Weighted Average Cost of Capital (WACC) | 6.94% |
| Revenue Per Employee | 904,098 |
| Profits Per Employee | 5,364 |
| Employee Count | 5,492 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.70 |
Taxes
In the past 12 months, SHA:600518 has paid 24.11 million in taxes.
| Income Tax | 24.11M |
| Effective Tax Rate | 43.37% |
Stock Price Statistics
The stock price has decreased by -37.79% in the last 52 weeks. The beta is 0.49, so SHA:600518's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -37.79% |
| 50-Day Moving Average | 1.37 |
| 200-Day Moving Average | 1.65 |
| Relative Strength Index (RSI) | 45.30 |
| Average Volume (20 Days) | 156,860,553 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:600518 had revenue of CNY 4.97 billion and earned 29.46 million in profits. Earnings per share was 0.00.
| Revenue | 4.97B |
| Gross Profit | 943.70M |
| Operating Income | -242.03M |
| Pretax Income | 55.59M |
| Net Income | 29.46M |
| EBITDA | 26.81M |
| EBIT | -242.03M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 1.35 billion in cash and 168.86 million in debt, with a net cash position of 1.18 billion or 0.09 per share.
| Cash & Cash Equivalents | 1.35B |
| Total Debt | 168.86M |
| Net Cash | 1.18B |
| Net Cash Per Share | 0.09 |
| Equity (Book Value) | 7.36B |
| Book Value Per Share | 0.53 |
| Working Capital | 1.56B |
Cash Flow
In the last 12 months, operating cash flow was 229.52 million and capital expenditures -217.71 million, giving a free cash flow of 11.80 million.
| Operating Cash Flow | 229.52M |
| Capital Expenditures | -217.71M |
| Depreciation & Amortization | 268.84M |
| Net Borrowing | -83.69M |
| Free Cash Flow | 11.80M |
| FCF Per Share | 0.00 |
Margins
Gross margin is 19.01%, with operating and profit margins of -4.87% and 0.59%.
| Gross Margin | 19.01% |
| Operating Margin | -4.87% |
| Pretax Margin | 1.12% |
| Profit Margin | 0.59% |
| EBITDA Margin | 0.54% |
| EBIT Margin | -4.87% |
| FCF Margin | 0.24% |
Dividends & Yields
SHA:600518 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.02% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 17.16% |
| Shareholder Yield | 17.16% |
| Earnings Yield | 0.16% |
| FCF Yield | 0.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 16, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Jun 16, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
SHA:600518 has an Altman Z-Score of 0.61 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.61 |
| Piotroski F-Score | 5 |